13 February 2025
Linklaters advises on Sammaan Capital’s qualified institutional placement of shares in India
Linklaters advised the book running lead managers on the US$150m qualified institutional placement (QIP) of shares for Sammaan Capital (formerly Indiabulls Housing Finance), the third largest private housing finance company in India.
The offering saw strong demand from investors including marquee investors such as US-based investment firm Capital Group and London-based hedge fund Marshall Wace, underscoring the market robustness and the investment opportunities in the Indian capital market.
Sammaan Capital is a mortgage-focussed non-banking financial company, with a strong nationwide presence with over 200 branches, offering home loans and loans to MSMEs and small businesses for working capital.
The Linklaters team was led by partner and head of India practice Amit Singh, with support from counsel Joseph Wolpin, and associates Alex Cui and Utkarsh Mishra.
Linklaters has an established track record as the leading Indian capital markets practice, offering technical expertise and commercial awareness to create novel solutions for maximising investment opportunities. The team supports international clients and leading Indian corporates as they invest both within and outside India across equity and debt capital markets including the recent QIP for Samvardhana Motherson International Limited and Sona BLW Precision Forgings Limited, recent IPO of Sai Life Sciences and the landmark high yield debut for Biocon Biologics.
The offering saw strong demand from investors including marquee investors such as US-based investment firm Capital Group and London-based hedge fund Marshall Wace, underscoring the market robustness and the investment opportunities in the Indian capital market.
Sammaan Capital is a mortgage-focussed non-banking financial company, with a strong nationwide presence with over 200 branches, offering home loans and loans to MSMEs and small businesses for working capital.
The Linklaters team was led by partner and head of India practice Amit Singh, with support from counsel Joseph Wolpin, and associates Alex Cui and Utkarsh Mishra.
Linklaters has an established track record as the leading Indian capital markets practice, offering technical expertise and commercial awareness to create novel solutions for maximising investment opportunities. The team supports international clients and leading Indian corporates as they invest both within and outside India across equity and debt capital markets including the recent QIP for Samvardhana Motherson International Limited and Sona BLW Precision Forgings Limited, recent IPO of Sai Life Sciences and the landmark high yield debut for Biocon Biologics.
